Local view for "http://purl.org/linkedpolitics/eu/plenary/2006-04-04-Speech-2-163"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2006-04-04"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20060404.18.2-163"2
lpv:hasSubsequent	lp_eu:2006-04-04-Speech-2-1652
lpv:speaker	lp:Peter Skinner2
lpv:spoken text	". Whilst we support the intention of Amendment 3 to alleviate the costs of healthcare and drugs for many of the poorest countries, this amendment is inappropriate as it provides for a blanket limit to all patent protections for products related to this field, which could distort markets at a global level and, potentially, harm further development. These issues are best dealt with at the level of the UN and WHO. The EPLP maintains its position on the issue of corporate taxation, which is not to support a recalculation of the corporate tax base. Whilst we seek greater coordination of tax authorities in trying to assist SMEs involved in cross-border trade, we acknowledge that this issue remains the competence of the EU Member States."@en1
lpv:spokenAs	substitute; ITRE (2004-07-21--2007-01-14)3 member; Delegation for relations with the United States (2004-09-15--2007-03-13)3 unknown; Labour Party (2004-07-20--2009-07-13)3 substitute; Delegation for relations with Switzerland, Iceland and Norway and to the European Economic Area (EEA) Joint Parliamentary Committee (2004-09-15--2009-07-13)3 member; Committee of Inquiry into the crisis of the Equitable Life Assurance Society (2006-01-19--2007-06-19)3 member; PES (2004-07-20--2009-07-13)3 member; ECON (2004-07-21--2007-01-14)3
lpv:unclassifiedMetadata	"Peter Skinner (PSE ),"1 "in writing"1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph